Shandong Sito Bio-technology Co., Ltd. (300583.SZ)
CNY 22.9
(-0.82%)
CNY 22.9
(-0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -92.84 Million | 145.33 Million | 227.34 Million | 254.6 Million | 57.61 Million | -334.41 Million |
| Net Income | 48.54 Million | 42.47 Million | 35.78 Million | -189.61 Million | 49.04 Million | 126.94 Million |
| Depreciation & Amortization | 173.56 Million | 163.23 Million | 135.44 Million | 142.86 Million | 82.64 Million | 67.69 Million |
| Deferred income taxes | -3.01 Million | -6.66 Million | 1.52 Million | -2.83 Million | -876.74 Thousand | 2 Million |
| Stock-based compensation | - | - | - | -4.82 Million | 76.92 Thousand | 8.3 Million |
| Change in working capital | -369.21 Million | -97.15 Million | 11.03 Million | 198.24 Million | -92.27 Million | -528.78 Million |
| Other non-cash items | 39.7 Million | 36.78 Million | 45.08 Million | 103.1 Million | 18.19 Million | -278.25 Thousand |
| Investing Cash Flow | -98.51 Million | -140.73 Million | -361.48 Million | -29.22 Million | 13.17 Million | -223.93 Million |
| Investments in PPE | -94.05 Million | -143.67 Million | -388.92 Million | -242.59 Million | -210.73 Million | -220.86 Million |
| Acquisitions | 788.55 Thousand | 170.4 Thousand | 14.27 Million | 3.13 Million | -179.27 Million | 6.91 Million |
| Investment purchases | -3 Million | - | -14.27 Million | -968.01 Million | 102.76 Thousand | -2.53 Million |
| Sales/Maturities of investments | 5.26 Million | - | 14.26 Million | 6.33 Million | 13.33 Million | 34.55 Million |
| Other Investing Activities | -7.51 Million | 2.77 Million | 13.17 Million | 1.17 Billion | 389.75 Million | -41.99 Million |
| Financing Cash Flow | 319.76 Million | -4.98 Million | -47.66 Million | -140.73 Million | 8.97 Million | 344.87 Million |
| Debt repayment | -80.64 Million | -671.86 Million | -483.35 Million | -632.48 Million | -725.94 Million | -377.19 Million |
| Dividends payments | -32.28 Million | -1.6 Million | -24.51 Million | -5.5 Million | -15.06 Million | -24.76 Million |
| Common Stock Repurchased | - | -7.99 Million | -4.89 Million | -7.94 Million | -5.01 Million | - |
| Common Stock Issuance | -1.15 Million | 7.99 Million | 4.89 Million | 7.94 Million | 5.01 Million | - |
| Other Financing Activities | 271.4 Million | 711.29 Million | 460.2 Million | 529.38 Million | 782.77 Million | 746.82 Million |
| Accounts receivables | -142.68 Million | -26.95 Million | -103.06 Million | -85.95 Million | -99.12 Million | -160.39 Million |
| Accounts payables | -95.99 Million | 14.72 Million | 123.54 Million | 91.37 Million | 68.74 Million | 64.39 Million |
| Inventory | -127.52 Million | -78.26 Million | -10.97 Million | 195.65 Million | -61.01 Million | -433.51 Million |
| Other working capital | -99 Million | -6.66 Million | 1.52 Million | -2.83 Million | -876.74 Thousand | -95.26 Million |
| Cash at beginning of period | 57.24 Million | 59.55 Million | 241.99 Million | 159.51 Million | 79.53 Million | 290.87 Million |
| Cash at end of period | 180.13 Million | 57.24 Million | 59.55 Million | 241.99 Million | 159.51 Million | 74.66 Million |
| Capital Expenditure | -94.05 Million | -143.67 Million | -388.92 Million | -242.59 Million | -210.73 Million | -220.86 Million |
| Effect of forex changes on cash | -5.52 Million | -1.92 Million | -631.62 Thousand | -2.16 Million | 212.91 Thousand | -2.74 Million |
| Net cash flow / Change in cash | 122.88 Million | -2.31 Million | -182.43 Million | 82.47 Million | 79.98 Million | -216.21 Million |
| Free Cash Flow | -186.9 Million | 1.65 Million | -161.57 Million | 12 Million | -153.11 Million | -555.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.5 Million | 10.14 Million | 3.07 Million | -15.55 Million | 48.54 Million | 1.18 Million |
| Depreciation & Amortization | - | 44.7 Million | 44.7 Million | 173.56 Million | 173.56 Million | -85.67 Million |
| Deferred income taxes | - | - | - | - | -3.01 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -147.09 Million | - | -270.21 Million | -369.21 Million | 366.47 Million |
| Other non-cash items | 80.67 Million | 100.14 Million | 18.17 Million | 93.21 Million | 39.7 Million | -233.22 Million |
| Investing Cash Flow | -38.45 Million | -9.93 Million | -12.9 Million | -474.82 Thousand | -98.51 Million | -34.02 Million |
| Investments in PPE | -37.02 Million | -9.98 Million | -16.65 Million | 4.4 Million | -94.05 Million | -36.52 Million |
| Acquisitions | 7.82 | 46.1 Thousand | - | 149.97 Thousand | 788.55 Thousand | -394.86 |
| Investment purchases | - | - | - | - | -3 Million | - |
| Sales/Maturities of investments | - | - | - | - | 5.26 Million | - |
| Other Investing Activities | -1.42 Million | 46.1 Thousand | 3.74 Million | -5.02 Million | -7.51 Million | 2.5 Million |
| Financing Cash Flow | -138.4 Million | -154.85 Million | 101.26 Million | 18.41 Million | 319.76 Million | -78.98 Million |
| Debt repayment | -43.62 Million | -101.01 Million | -77.77 Million | -2.28 Million | -80.64 Million | -33.42 Million |
| Dividends payments | -90.96 Million | -6.63 Million | -9.57 Million | -1.77 Million | -1.77 Million | -6.51 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -1.15 Million | -1.15 Million | - |
| Other Financing Activities | -3.81 Million | -47.2 Million | 33.06 Million | 31.2 Million | 271.4 Million | -39.04 Million |
| Accounts receivables | - | -182.18 Million | - | -142.68 Million | -142.68 Million | 192.39 Million |
| Accounts payables | - | - | - | - | -95.99 Million | - |
| Inventory | - | 35.09 Million | - | -127.52 Million | -127.52 Million | 174.07 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 189.42 Million | 290.02 Million | 180.13 Million | 182.62 Million | 57.24 Million | 254.12 Million |
| Cash at end of period | 94.89 Million | 189.42 Million | 290.02 Million | 180.13 Million | 180.13 Million | 182.62 Million |
| Capital Expenditure | -37.02 Million | -9.98 Million | -16.65 Million | 4.4 Million | -94.05 Million | -36.52 Million |
| Effect of forex changes on cash | 156.21 Thousand | -1.39 Million | 292.99 Thousand | -1.44 Million | -5.52 Million | -1.99 Million |
| Net cash flow / Change in cash | -94.52 Million | -100.6 Million | 109.89 Million | -2.49 Million | 122.88 Million | -71.49 Million |
| Free Cash Flow | 45.14 Million | 55.6 Million | 4.59 Million | -14.57 Million | -186.9 Million | 12.24 Million |
058860
3513
MLCG
LBTI
GEGR
RBTEF